AA |
anthranilic acid |
Aβ |
amyloid-β |
AD |
Alzheimer’s disease |
AhR |
aryl hydrocarbon receptor |
AIDS |
acquired immune deficiency syndrome
|
ALS |
amyotrophic lateral sclerosis |
AMPA |
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
APC |
antigen-presenting cell |
ASC |
apoptosis-associated speck-like protein containing caspase activation and recruitment domains |
BBB |
blood–brain barrier |
CA |
cinnabarinic acid |
CD |
cluster of differentiation |
Cdh1 |
cadherin 1 |
CARD |
caspase activation and recruitment domains |
cART |
combination antiretroviral therapies |
CCL5 |
C–C motif chemokine ligand 5 |
CJD |
Creutzfeldt–Jakob disease |
CNS |
central nervous system |
CSF |
cerebrospinal fluid |
DLB |
dementia with Lewy bodies |
GC |
glucocorticoid |
GPR35 |
G-protein-coupled receptor 35 |
3-HAA |
3-hydroxy-anthralinic acid |
HAND |
HIV-associated neurocognitive disorders |
HD |
Huntington’s disease |
HIV |
human immunodeficiency virus |
3-HK |
3-hydroxy-kynurenine |
IFN |
interferon |
LB |
Lewy body |
IL |
interleukin |
KAT |
kynurenine aminotransferase |
KMO |
kynurenine-3-monooxygenase |
KYN |
kynurenine |
KYNA |
kynurenic acid |
MIP |
macrophage inflammatory proteins |
MS |
multiple sclerosis |
ND |
neurodegenerative diseases |
NMDA |
N-methyl-d-aspartate |
OA |
oxidative stress |
PA |
picolinic acid |
PD |
Parkinson’s disease |
PLP |
pyridoxal phosphate |
PrPC
|
cellular prion protein |
PrPSc
|
scrapie isoform of the prion protein |
QA |
quinolinic acid |
RANTES |
regulated upon activation, normal T cell expressed, and presumably secreted |
RBC |
red blood cell |
RNS |
reactive nitrogen species |
ROS |
reactive oxygen species |
SND |
stroke-induced secondary neurodegeneration |
TDO |
tryptophan dioxygenase |
TDP |
transactive response DNA-binding protein |
TGF |
transforming growth factor |
Th |
T helper |
TNF |
tumor necrosis factor |
Tregs |
regulatory T cells |
TRP |
tryptophan |
VEGF |
vascular endothelial growth factor |
XA |
xanthurenic acid |